18. Spinocerebellar degeneration Clinical trials / Disease details
Clinical trials : 71 / Drugs : 99 - (DrugBank : 30) / Drug target genes : 45 - Drug target pathways : 65
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2008-003662-25-IT (EUCTR) | 21/10/2009 | 01/10/2009 | Studio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - ND | Studio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - ND | Friedreich`s Ataxia (FRDA) MedDRA version: 9.1;Level: LLT;Classification code 10017374 | Product Name: Lu AA24493 Product Code: Lu AA24493 | H.Lundbeck A/S | NULL | Not Recruiting | Female: yes Male: yes | 36 | Germany;Italy;Austria | |||
| 2 | EUCTR2008-003662-25-AT (EUCTR) | 02/10/2009 | 14/08/2009 | Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy | Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy | Friedreich's Ataxia (FRDA) MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia | Product Name: Lu AA24493 Product Code: Lu AA24493 | H. Lundbeck A/S | NULL | Not Recruiting | Female: yes Male: yes | 36 | Germany;Italy;Austria | |||
| 3 | EUCTR2008-003662-25-DE (EUCTR) | 21/08/2009 | Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy | Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy | Friedreich's Ataxia (FRDA) MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia | Product Name: Lu AA24493 Product Code: Lu AA24493 | H. Lundbeck A/S | NULL | Not Recruiting | Female: yes Male: yes | 36 | Austria;Germany;Italy |